IMNN-001 for fallopian tube neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Jan 2018: Trial registered, NCT03393884
  2. 5 Sep 2018: Trial started, NCT03393884

The trials

NCT03393884: Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

State
Under way
Phase
Phase 1 and Phase 2
People
130 planned
Started
5 Sep 2018
Primary completion
25 Jul 2024
Arms
NACT + IMNN-001
Results
None posted
  1. 9 Jan 2018: Trial registered
  2. 5 Sep 2018: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.